Avg closing price
Price range

7 Cathie Wood Verve Therapeutics Trades

Cathie Wood acquired 4.37 Million Verve Therapeutics shares worth $99.3 Million. That's 0.69% of their equity portfolio (27th largest holding). The investor owns 7.33% of the outstanding Verve Therapeutics stock. The investor's estimated purchase price is $153 Million, resulting in a loss of 35%.

Avg closing price
Price range
Increased shares by 28.6% (+972 Thousand shares) Q4 2022
Avg closing price $26.50
Price range $17.85 - $40.70
Increased shares by 66.8% (+1.36 Million shares) Q3 2022
Avg closing price $31.92
Price range $15.63 - $41.49
Increased shares by 20.6% (+347 Thousand shares) Q2 2022
Avg closing price $15.49
Price range $11.14 - $23.17
Increased shares by 20.5% (+287 Thousand shares) Q1 2022
Avg closing price $28.58
Price range $20.92 - $39.36
Increased shares by 10.4% (+132 Thousand shares) Q4 2021
Avg closing price $42.01
Price range $31.94 - $54.82
Increased shares by 131.2% (+719 Thousand shares) Q3 2021
Avg closing price $58.83
Price range $46.00 - $73.99
New holding (+548 Thousand shares) Q2 2021
Avg closing price $41.51
Price range $31.92 - $60.25

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!